ARTFEED — Contemporary Art Intelligence

AI Designs and Runs 36,000 Biological Experiments Autonomously

ai-technology · 2026-06-05

OpenAI and Ginkgo Bioworks announced in February 2026 that GPT-5 autonomously designed and ran 36,000 biological experiments via a robotic cloud laboratory, cutting protein production costs by 40%. This marks a leap in programmable biology, where AI closes the design-build-test-learn loop. However, biosecurity governance lags behind. The Biden administration's 2023 executive order on AI security was revoked by Trump; synthetic DNA screening remains voluntary. A 2026 bipartisan bill does not address AI-designed sequences. The 1975 Biological Weapons Convention lacks AI provisions. Studies show AI can help novices complete biosecurity tasks with 4x greater accuracy (Scale AI/SecureBio) or show no significant difference (Active Site). Anthropic and OpenAI have imposed voluntary safety measures, but CEO Dario Amodei warned that AI development may outpace single-company risk assessment. The Nuclear Threat Initiative proposed a managed access framework for biological AI tools.

Key facts

  • OpenAI and Ginkgo Bioworks announced in February 2026 that GPT-5 autonomously designed and ran 36,000 biological experiments.
  • The experiments were conducted via a robotic cloud laboratory, cutting protein production costs by 40%.
  • AI-driven programmable biology enables thousands of design variations in parallel, iterating like engineering.
  • The Biden administration's 2023 executive order on AI security with biosecurity provisions was revoked by the Trump administration.
  • Synthetic DNA screening remains mostly voluntary; a 2026 bipartisan bill does not address AI-designed sequences.
  • The 1975 Biological Weapons Convention contains no provisions for AI.
  • A Scale AI/SecureBio study found novices with LLMs completed biosecurity tasks with 4x greater accuracy; 90% reported little difficulty getting risky information despite safety filters.
  • An Active Site study found AI help did not lead to significant differences in novices' ability to produce a virus in a biosafety lab.
  • Anthropic activated its highest safety tier for its most advanced model in mid-2025; OpenAI updated its Preparedness Framework.
  • Anthropic CEO Dario Amodei wrote that AI development may outrun any single company's ability to assess risk.
  • The Nuclear Threat Initiative proposed a managed access framework for biological AI tools.
  • The RAND Center on AI, Security and Technology outlined actions including improved DNA synthesis screening and model evaluations.
  • Researchers estimated that modest AI improvements in planning pathogen experiments could translate to thousands of additional deaths from bioterrorism per year.

Entities

Institutions

  • OpenAI
  • Ginkgo Bioworks
  • Scale AI
  • SecureBio
  • Active Site
  • Nuclear Threat Initiative
  • RAND Center on AI, Security and Technology
  • Anthropic
  • UK AI Security Institute
  • US National Security Commission on Emerging Biotechnology
  • University of Virginia School of Data Science
  • The Conversation
  • SingularityHub

Locations

  • United States
  • UK

Sources